- $329.93m
- $363.04m
- $488.07m
- 44
- 62
- 36
- 44
C2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 636 | 557 | 616 | 538 | 488 |
Cost of Revenue | |||||
Gross Profit | 281 | 223 | 264 | 214 | 196 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 693 | 676 | 649 | 658 | 894 |
Operating Profit | -57.1 | -119 | -33.1 | -120 | -406 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -65.1 | -143 | 320 | -121 | -362 |
Provision for Income Taxes | |||||
Net Income After Taxes | -69.6 | -150 | 322 | -123 | -362 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -69.9 | -150 | 322 | -123 | -363 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -69.9 | -150 | 322 | -123 | -363 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.613 | -0.986 | 2.55 | -0.942 | -1.18 |